P2.06-021 Efficacy and Safety of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment in Subjects with EGFRMut+ NSCLC
Saved in:
Published in | Journal of thoracic oncology Vol. 12; no. 1; pp. S1083 - S1084 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.01.2017
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 1556-0864 |
---|---|
DOI: | 10.1016/j.jtho.2016.11.1514 |